FallberichtOpen Access
Clinical Outcomes of Abrocitinib in Prurigo Spectrum Disorders: A Case Series
Cureus · 23.04.2026
DOI: 10.7759/cureus.107619 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cureus, erschienen am 23.04.2026. Verfasst von Uma Chakravadhanula und 2 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology, Institute of Diabetes, Endocrinology, and Adiposity (IDEA) Clinics, Hyderabad, IND. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
abrocitinibitchingjak inhibitorprurigo nodularisprurigo simplex
Autor:innen und Institutionen
- Dermatology, Institute of Diabetes, Endocrinology, and Adiposity (IDEA) Clinics, Hyderabad, IND.
- Dermatology, SAAR Clinic, Erode, IND.
- Dermatology, Subodha Skin, Hair, and Cosmetic Clinic, Bangalore, IND.
Zitieren
APA
Chakravadhanula, U., Nagarajan, M., & Bhat, S. (2026). Clinical Outcomes of Abrocitinib in Prurigo Spectrum Disorders: A Case Series. Cureus. https://doi.org/10.7759/cureus.107619
Vancouver
Chakravadhanula U, Nagarajan M, Bhat S. Clinical Outcomes of Abrocitinib in Prurigo Spectrum Disorders: A Case Series. Cureus. 2026. doi:10.7759/cureus.107619
BibTeX
@article{Chakravadhanula2026,
author = {Chakravadhanula, Uma and Nagarajan, Manjula and Bhat, Shilpa},
title = {Clinical Outcomes of Abrocitinib in Prurigo Spectrum Disorders: A Case Series},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.107619}
}
EUVIMED